Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?

Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?

Abstract Severe asthma has a substantial epidemiological impact on children and biological treatments can be an option to take into account, as they target specific molecules and pathways involved in its pathogenesis. Modern medicine is continuously and progressively oriented towards tailored treatm...

Full description

Bibliographic Details
Main Authors: Mattia Giovannini, Francesca Mori, Simona Barni, Maurizio de Martino, Elio Novembre
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Italian Journal of Pediatrics
Subjects:
omalizumab
mepolizumab
biological therapy
severe asthma
children
Online Access:https://doi.org/10.1186/s13052-019-0737-4

Similar Items

Similar Items